 |
인쇄하기
취소
|
Daiho anti-cancer drug jointly to conduct clinical phase II studies in Korea.
A local clinical study on a new anti-cancer drug for the treatment of metastatic breast cancer patients starting from Oct. 23.
McChem Health and Yonsei University Cancer Center jointly reported on Oct. 23 that a phase II local clinical study for TSU 68, an anti-cancer drug developed by Daiho Japan, will be conducted in Korea especially for the breast cancer patients who are recurrent or alre...
McChem Health and Yonsei University Cancer Center jointly reported on Oct. 23 that a phase II local clinical study for TSU 68, an anti-cancer drug developed by Daiho Japan, will be conducted in Korea especially for the breast cancer patients who are recurrent or alre...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.